Cholinergic signaling exerts protective effects in models of sympathetic hyperactivity-induced cardiac dysfunction

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Gavioli, Mariana ^a   Lara, Aline ^a   Almeida, Pedro W M ^a   Lima, Augusto Martins ^a   Damasceno, Denis D ^a   Rocha Resende, Cibele ^a   Ladeira, Marina ^a   Resende, Rodrigo R ^a   Martinelli, Patricia M ^a   Melo, Marcos Barrouin ^a   Brum, Patricia C ^b   Fontes, Marco Antonio Peliky ^a   Souza Santos, Robson A ^a   Prado, Marco A M ^c   Guatimosim, Silvia ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CHOLINESTERASE; ISOPRENALINE; PYRIDOSTIGMINE; CARDIOTONIC AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC DYSFUNCTION; BETA ADRENERGIC STIMULATION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME INHIBITION; GENE INACTIVATION; HEART DISEASE; HEART PROTECTION; HEART VENTRICLE CONTRACTION; MALE; MOUSE; NEUROLOGIC DISEASE; NEWBORN; NONHUMAN; PARASYMPATHETIC TONE; RAT; SIGNAL TRANSDUCTION; SYMPATHETIC HYPERACTIVITY; SYMPATHETIC TONE; UPREGULATION; ANIMAL; AUTONOMIC NERVOUS SYSTEM; C57BL MOUSE; CARDIAC MUSCLE CELL; CELL CULTURE; DRUG EFFECTS; IN VITRO STUDY; KNOCKOUT MOUSE; WISTAR RAT;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; CARDIOTONIC AGENTS; CELLS, CULTURED; CHOLINERGIC AGENTS; CHOLINESTERASE INHIBITORS; IN VITRO TECHNIQUES; ISOPROTERENOL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, CARDIAC; PYRIDOSTIGMINE BROMIDE; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84903771646     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100179     Document Type: Article

References (32)

1. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, et al. (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344: 1651-1658. (Pubitemid 32479962)
2. Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, et al. (2002) Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 106: 2194-2199. (Pubitemid 35222212)
3. Rockman HA, Koch WJ, Lefkowitz RJ (2002) Seven-transmembrane-spanning receptors and heart function. Nature 415: 206-212. (Pubitemid 34059526)
4. de Castro BM, Pereira GS, Magalhaes V, Rossato JI, De J, X, et al. (2009) Reduced expression of the vesicular acetylcholine transporter causes learning deficits in mice. Genes Brain Behav 8: 23-35.
5. Prado VF, Martins-Silva C, de Castro BM, Lima RF, Barros DM, et al. (2006) Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 51: 601-612. (Pubitemid 44314080)
6. LaCroix C, Freeling J, Giles A, Wess J, Li YF (2008) Deficiency of M2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress. Am J Physiol Heart Circ Physiol 294: H810-H820. (Pubitemid 351253292)
7. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, et al. (2004) Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109: 120-124. (Pubitemid 38056032)
8. Lara A, Damasceno DD, Pires R, Gros R, Gomes ER, et al. (2010) Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure. Mol Cell Biol 30: 1746-1756.
9. Freeling J, Wattier K, LaCroix C, Li YF (2008) Neostigmine and pilocarpine attenuated tumour necrosis factor alpha expression and cardiac hypertrophy in the heart with pressure overload. Exp Physiol 93: 75-82. (Pubitemid 350293968)
10. Okazaki Y, Zheng C, Li M, Sugimachi M (2010) Effect of the cholinesterase inhibitor donepezil on cardiac remodeling and autonomic balance in rats with heart failure. J Physiol Sci 60: 67-74.
11. Handa T, Katare RG, Kakinuma Y, Arikawa M, Ando M, et al. (2009) Anti-Alzheimer's drug, donepezil, markedly improves long-term survival after chronic heart failure in mice. J Card Fail 15: 805-811.
12. Kanazawa H, Ieda M, Kimura K, Arai T, Kawaguchi-Manabe H, et al. (2010) Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodents. J Clin Invest 120: 408-421.
13. Nordstrom P, Religa D, Wimo A, Winblad B, Eriksdotter M (2013) The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease. Eur Heart J 34: 2585-2591.
14. Kakinuma Y, Akiyama T, Sato T (2009) Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium. FEBS J 276: 5111-5125.
15. Rana OR, Schauerte P, Kluttig R, Schroder JW, Koenen RR, et al. (2010) Acetylcholine as an age-dependent non-neuronal source in the heart. Auton Neurosci 156: 82-89.
16. Rocha-Resende C, Roy A, Resende R, Ladeira MS, Lara A, et al. (2012) Non-neuronal cholinergic machinery present in cardiomyocytes offsets hypertrophic signals. J Mol Cell Cardiol 53: 206-216.
17. Roy A, Fields WC, Rocha-Resende C, Resende RR, Guatimosim S, et al. (2013) Cardiomyocyte-secreted acetylcholine is required for maintenance of homeostasis in the heart. FASEB J 27: 5072-5082.
18. Oliveira EM and Krieger JE (2005) Chronic beta-adrenoceptor stimulation and cardiac hypertrophy with no induction of circulating renin. Eur J Pharmacol 520: 135-141. (Pubitemid 41375821)
19. Bartholomeu JB, Vanzelli AS, Rolim NP, Ferreira JC, Bechara LR, et al. (2008) Intracellular mechanisms of specific beta-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure. J Mol Cell Cardiol 45: 240-249.
20. De AK, Wichi RB, Jesus WR, Moreira ED, Morris M, et al. (2004) Exercise training changes autonomic cardiovascular balance in mice. J Appl Physiol 96: 2174-2178. (Pubitemid 38661498)
21. Negrao CE, Moreira ED, Brum PC, Denadai ML, Krieger EM (1992) Vagal and sympathetic control of heart rate during exercise by sedentary and exercise-trained rats. Braz J Med Biol Res 25: 1045-1052.
22. Marques FD, Ferreira AJ, Sinisterra RD, Jacoby BA, Sousa FB, et al. (2011) An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats. Hypertension 57: 477-483.
23. Marques FD, Melo MB, Souza LE, Irigoyen MC, Sinisterra RD, et al. (2012) Beneficial effects of long-term administration of an oral formulation of Angiotensin-(1-7) in infarcted rats. Int J Hypertens 2012: 795452.
24. Gava E, de Castro CH, Ferreira AJ, Colleta H, Melo MB, et al. (2012) Angiotensin-(1-7) receptor Mas is an essential modulator of extracellular matrix protein expression in the heart. Regul Pept 175: 30-42.
25. Castro CH, Santos RA, Ferreira AJ, Bader M, Alenina N, et al. (2005) Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart. Hypertension 46: 937-942.
26. Ferreira AJ, Oliveira TL, Castro MC, Almeida AP, Castro CH, et al. (2007) Isoproterenol-induced impairment of heart function and remodeling are attenuated by the nonpeptide angiotensin-(1-7) analogue AVE 0991. Life Sci 81: 916-923. (Pubitemid 47374211)
27. Guatimosim S, Sobie EA, dos Santos CJ, Martin LA, Lederer WJ (2001) Molecular identification of a TTX-sensitive Ca(2+) current. Am J Physiol Cell Physiol 280: C1327-C1339.
28. Guatimosim S, Amaya MJ, Guerra MT, Aguiar CJ, Goes AM, et al. (2008) Nuclear Ca2+ regulates cardiomyocyte function. Cell Calcium 44: 230-242.
29. Rolim NP, Medeiros A, Rosa KT, Mattos KC, Irigoyen MC, et al. (2007) Exercise training improves the net balance of cardiac Ca2+ handling protein expression in heart failure. Physiol Genomics 29: 246-252. (Pubitemid 47173296)
30. Kakinuma Y, Tsuda M, Okazaki K, Akiyama T, Arikawa M, et al. (2013) Heart-specific overexpression of choline acetyltransferase gene protects murine heart against ischemia through hypoxia-inducible factor-1alpha-related defense mechanisms. J Am Heart Assoc 2: e004887.
31. Sabino JP, da Silva CA, de Melo RF, Fazan R, Jr., Salgado HC (2013) The treatment with pyridostigmine improves the cardiocirculatory function in rats with chronic heart failure. Auton Neurosci 173: 58-64.
32. Lataro RM, Silva CA, Fazan R, Jr., Rossi MA, Prado CM, et al. (2013) Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure. Am J Physiol Regul Integr Comp Physiol 305: R908-R916.